Application of fusion gene detection technology based on capture sequencing in the diagnosis of skin and soft tissue diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035530

Enrollment

Unknown

Registered

2020-08-13

Start date

2020-09-01

Completion date

Unknown

Last updated

2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and soft tissue diseases

Interventions

Patients with skin and soft tissue diseases and control group:nill

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The clinical manifestations of dermatofibrosarcoma protuberans, melanoma, Spitz nevus and other skin and soft tissue diseases, as well as the pathological diagnosis were confirmed at the same time; 2. Any age male and female; 3. Vital signs are stable; 4. The subject or guardian has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The patient has identified the the fusion gene for skin and soft tissue diseases; 2. At the discretion of the investigator, the subjects were either untrustworthy or poorly compliant.

Design outcomes

Primary

Measure	Time frame
Fusion gene;	—

Countries

China

Contacts

Public ContactYun BAI

Shanghai Skin Disease Hospital

baiyun@chgc.sh.cn+86 15801777141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026